| Langelier, Marie-France; Mirhasan, Manija; Gilbert, Karine; Sverzhinksy, Aleksandr; Furtos, Alexandra et al. (2024). PARP enzyme de novo synthesis of protein-free poly(ADP-ribose). Molecular Cell 84(24) , 4758-4773.e6. 10.1016/j.molcel.2024.10.024. [PDB: 9bpy, 9dmc] |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Krishnan, Shreya S; Shen, Yao; O’Hagan, Treasa B; Matthews, Lindsay A; Weerasinghe, Nuwani W et al. (2025). Asymmetric loading of TnsE regulates Tn7 targeting of DNA replication structures. Nucleic Acids Research 53(11) . 10.1093/nar/gkaf472. |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Kinzel, Olaf; Goldberg, Steven D.; Cummings, Maxwell D.; Gege, Christian; Steeneck, Christoph et al. (2025). Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of Psoriasis. Journal of Medicinal Chemistry 68(8) , 8713-8728. 10.1021/acs.jmedchem.5c00390. [PDB: 9n9l] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Ketcham, John M.; Harwood, Stephen J.; Aranda, Ruth; Aloiau, Athenea N.; Bobek, Briana M. et al. (2024). Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c00078. [PDB: 8v8h] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kassardjian, Audrey; Ivanochko, Danton; Barber, Brian; Jetha, Arif; Julien, Jean-Philippe et al. (2024). Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. Antibodies 13(3) , 57. 10.3390/antib13030057. [PDB: 9b7b] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kalugin, Denis; Bahig, Jumanah; Shoker, Ahmed; Doan, Huu; Kirychuk, Shelley et al. (2024). Superhydrophobic polyether sulfone (PES) dialysis membrane with enhanced hemocompatibility and reduced human serum protein interactions: Ex vivo, in situ synchrotron imaging, experimental, and computational studies. Separation and Purification Technology 335, 126071. 10.1016/j.seppur.2023.126071. |
BMIT-BM |
Peer-Reviewed Article |
Health |
| Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |